Brain Insulin Impairs Amyloid-β(1-40) Clearance from the Brain
Authors:
- Takeshi ShiikiTSTakeshi Shiiki
- Sumio OhtsukiSOSumio Ohtsuki
- Atsushi KuriharaAKAtsushi Kurihara
- Hideo NaganumaHNHideo Naganuma
- Kenji NishimuraKNKenji Nishimura
- Tetsuya TerasakiTTTetsuya Terasaki
Open Access
- 27 October 2004
- journal article
- Published by Society for Neuroscience in The Journal of Neuroscience
- Vol. 24 (43) , 9632-9637
Abstract
Cerebral amyloid-β peptide (Aβ) clearance plays a key role in determining the brain level of Aβ; however, its mechanism remains unclear. In this study, we investigated cerebral Aβ clearance across the blood-brain barrier (BBB) by using the Brain Efflux Index method. [125I]Aβ(1-40) was eliminated from rat brain to circulating blood with a half-life of 48.8 min and a half-saturation concentration of 8.15 nm. The Aβ(1-40) elimination rate was reduced by 30.5% in 23-month-old rats compared with 7-week-old rats. The intact form of Aβ(1-40) was detected in plasma after intracerebral administration, indicating the occurrence of efflux transport of intact Aβ(1-40). The Aβ(1-40) elimination rate was significantly inhibited by coadministration of 100 μg/ml insulin and 1 mmthiorphan by 44.6 and 34.0%, respectively. The level of intact [125I]Aβ(1-40) in the brain was increased by coadministration of insulin. Among insulin-degrading enzyme inhibitors, bacitracin inhibited the elimination rate, whereasN-ethylmaleimide and metal chelators had no effect. Receptor-associated protein, fucoidan, 3-bromo-5-t-butyl-4-hydroxy-benzylidenemalonitrile, anti-IGF-I receptor antibody, andl-tyrosine did not affect the Aβ(1-40) elimination rate, suggesting that the relevant receptors or transporters are not likely to be involved in the clearance. In conclusion, the present study has demonstrated the involvement of a proteolytic degradation process and an insulin-sensitive process in cerebral Aβ(1-40) clearance in the rat.Keywords
This publication has 27 references indexed in Scilit:
- Recent advances in the brain-to-blood efflux transport across the blood–brain barrierInternational Journal of Pharmaceutics, 2002
- Neprilysin Degrades Both Amyloid β Peptides 1–40 and 1–42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive EndopeptidasesJournal of Biological Chemistry, 2001
- Mediated efflux of IgG molecules from brain to blood across the blood–brain barrierJournal of Neuroimmunology, 2001
- Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrierJournal of Clinical Investigation, 2000
- Receptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain BarrierNeurobiology of Disease, 1999
- Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by DegradationJournal of Biological Chemistry, 1998
- Brain insulin and insulin receptors in aging and sporadic Alzheimer's diseaseJournal of Neural Transmission, 1998
- Specific Inhibition of Insulin-Like Growth Factor-1 and Insulin Receptor Tyrosine Kinase Activity and Biological Function by TyrphostinsEndocrinology, 1997
- Identification of residues in the insulin molecule important for binding to insulin-degrading enzymeBiochemistry, 1990
- An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue cultureBiochemical and Biophysical Research Communications, 1987